Boston Scientific BSX is gaining from new product launches and accretive acquisitions. Yet, unfavorable currency movement and ...

So far, BSX stock has risen 19% year-to-date. Separately, CROX reports earnings tomorrow. Will the stock pop on the news? See ...

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and ...

Boston Scientific, which generates most of its revenue ... beating estimates of $2.83 billion. The company's endoscopy unit, which includes devices used in surgical procedures that aid in weight ...

Boston Scientific apparently knows a good bet when it sees one. | That includes treating more than 200,000 patients with the irregular heartbeat known as atrial fibrillation—and the sum more than ...

The company primarily operates through its MedSurg (endoscopy, urology ... there’s a powerful fundamental story happening with Boston Scientific. Also, EPS is estimated to ramp higher this ...

Urology led the way with a 19.5% increase. Neuromodulation (+11.4%) and Endoscopy (7%) followed. Outlook: Boston Scientific forecasts net sales growth of approximately 12.5%-14.5% in 2025 on a ...

The headline numbers for Boston Scientific (BSX) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall ...